Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 4

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Thoracic 4Other hematologic neoplasm 1Lymphoid 1

Conditions

Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 2Tuberculosis, Pulmonary 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Complications 1Pneumonia 1Osteosarcoma 1Motor Activity 1Lung Injury 1Hypoxia 1Carcinoma, Renal Cell 1

Interventions

Carboplatin 346Cisplatin 240Paclitaxel 208Radiotherapy 207Pemetrexed 190Docetaxel 170Gemcitabine 158pembrolizumab 147Erlotinib Hydrochloride 111Magnetic Resonance Spectroscopy 102Etoposide 99Bevacizumab 96Specimen Handling 84Nivolumab 77Radiosurgery 74durvalumab 73Blood Specimen Collection 65Drug Therapy 61osimertinib 56Vinorelbine 54Gefitinib 50Surveys and Questionnaires 48atezolizumab 45Biopsy 43Radiation 42Irinotecan 42Topotecan 39Standard of Care 39Cyclophosphamide 38Surgical Procedures, Operative 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Lung Neoplasms × Thoracotomy × Clear all
NCT02502318 2024-01-12

LungSco01

Centre Hospitalier Universitaire Dijon

Phase NA Terminated
261 enrolled
Thoracic

Lung Neoplasms

NCT03658083 2022-04-27

ROSE

Teesside University

Completed
55 enrolled
Thoracic

Lung Neoplasms, Motor Activity

NCT04755478 2021-02-16

OPEN THORUS

Hospital General Universitario de Valencia

Unknown
30 enrolled
LymphoidOther hematologic neoplasmThoracic

Hypoxia, Lung Neoplasms, Pneumonia, Postoperative Complications, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Lung Injury

NCT02331056 2016-10-07

Could the Stroke Volume Variation Predict a Fluid Responsiveness in Thoracotomy?

Samsung Medical Center

Completed
79 enrolled
Thoracic

Lung Neoplasms, Tuberculosis, Pulmonary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡